Persistent Asset Partners LTD Portfolio Holdings

Persistent Asset Partners LTD

  • $121 Billion
  • Q4 2024

Persistent Asset Partners LTD has filed its 13F form on February 14, 2025 for Q4 2024 where it was disclosed a total value porftolio of $121 Billion distributed in 160 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Humana Inc with a value of $11.2B, Davita Inc. with a value of $7.6B, Unitedhealth Group Inc with a value of $6.41B, Pennant Group, Inc. with a value of $4.37B, and Cardinal Health Inc with a value of $4.18B.

Examining the 13F form we can see an increase of $121B in the current position value.

Persistent Asset Partners LTD is based out at Hong Kong, K3

Below you can find more details about Persistent Asset Partners LTD portfolio as well as his latest detailed transactions.

Portfolio value $121 Billion
Healthcare: $77.8 Billion
Financial Services: $27.6 Billion
Energy: $2.35 Billion
Basic Materials: $2.08 Billion
Consumer Cyclical: $1.43 Billion
Technology: $1.13 Billion
ETFs: $889 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$32.1B
$11.2 Billion 9.28% of portfolio
38,160
Q4 2024 New
$14.4B
$7.6 Billion 6.31% of portfolio
43,148
Q4 2024 New
$490B
$6.41 Billion 5.32% of portfolio
11,824
Q4 2024 New
$766M
$4.37 Billion 3.62% of portfolio
164,992
Q4 2024 New
$33.1B
$4.18 Billion 3.47% of portfolio
33,798
Q4 2024 New
Brightspring Health Svcs Inc
-
$4.04 Billion 3.35% of portfolio
-
Q4 2024 New
$2.56B
$3.76 Billion 3.12% of portfolio
244,154
Q4 2024 New
$8.39B
$3.51 Billion 2.91% of portfolio
341,366
Q4 2024 New
$32.2B
$2.85 Billion 2.37% of portfolio
44,545
Q4 2024 New
$3.73B
$2.73 Billion 2.26% of portfolio
60,455
Q4 2024 New
$426M
$2.5 Billion 2.07% of portfolio
297,123
Q4 2024 New
$32.1B
$2.19 Billion 1.82% of portfolio
994
Q4 2024 New
$86.4B
$2.19 Billion 1.81% of portfolio
38,697
Q4 2024 New
$85.3B
$2.04 Billion 1.69% of portfolio
3,433
Q4 2024 New
$164B
$2.02 Billion 1.68% of portfolio
24,853
Q4 2024 New
$53.5B
$1.87 Billion 1.55% of portfolio
9,320
Q4 2024 New
$4.98B
$1.69 Billion 1.4% of portfolio
19,151
Q4 2024 New
$1.17B
$1.66 Billion 1.38% of portfolio
18,641
Q4 2024 New
$1.05B
$1.65 Billion 1.37% of portfolio
65,235
Q4 2024 New
$11B
$1.63 Billion 1.35% of portfolio
10,744
Q4 2024 New
$2.91B
$1.53 Billion 1.27% of portfolio
234,030
Q4 2024 New
$304M
$1.49 Billion 1.24% of portfolio
150,035
Q4 2024 New
$443M
$1.5 Billion 1.24% of portfolio
56,715
Q4 2024 New
$210B
$1.33 Billion 1.1% of portfolio
13,422
Q4 2024 New
$838M
$1.28 Billion 1.07% of portfolio
68,343
Q4 2024 New
$1.31B
$1.21 Billion 1.0% of portfolio
15,532
Q4 2024 New
$225B
$1.19 Billion 0.99% of portfolio
1,864
Q4 2024 New
$802B
$1.19 Billion 0.99% of portfolio
1,468
Q4 2024 New
$8.04B
$1.17 Billion 0.97% of portfolio
8,940
Q4 2024 New
Soleno Therapeutics Inc
-
$1.1 Billion 0.91% of portfolio
-
Q4 2024 New
$5.61B
$1.09 Billion 0.9% of portfolio
9,693
Q4 2024 New
$3.21B
$1.09 Billion 0.9% of portfolio
18,312
Q4 2024 New
$54.6B
$1.06 Billion 0.88% of portfolio
20,315
Q4 2024 New
$13B
$1.02 Billion 0.85% of portfolio
64,600
Q4 2024 New
$2.58B
$977 Million 0.81% of portfolio
64,120
Q4 2024 New
$304B
$979 Million 0.81% of portfolio
12,428
Q4 2024 New
$11.9B
$952 Million 0.79% of portfolio
43,492
Q4 2024 New
$10.7B
$957 Million 0.79% of portfolio
12,500
Q4 2024 New
$559M
$948 Million 0.79% of portfolio
21,746
Q4 2024 New
$2.33B
$842 Million 0.7% of portfolio
10,558
Q4 2024 New
$1.34B
$832 Million 0.69% of portfolio
15,477
Q4 2024 New
$29.6B
$825 Million 0.68% of portfolio
57,041
Q4 2024 New
$4.03B
$819 Million 0.68% of portfolio
12,425
Q4 2024 New
$2.4B
$758 Million 0.63% of portfolio
92,022
Q4 2024 New
Apogee Therapeutics Inc
-
$742 Million 0.62% of portfolio
-
Q4 2024 New
$8.2B
$717 Million 0.59% of portfolio
26,147
Q4 2024 New
$4.46B
$709 Million 0.59% of portfolio
22,366
Q4 2024 New
$9.23B
$710 Million 0.59% of portfolio
7,941
Q4 2024 New
$945M
$648 Million 0.54% of portfolio
50,213
Q4 2024 New

Summary

  • Portfolio
  • No. of Stocks 160
  • Current Value $121 Billion
  • Filing
  • Period Q4 2024
  • Filing Date February 14, 2025
  • Form Type 13F-HR
  • Activity in Q4 2024
  • New Purchases 96 stocks
  • Additional Purchases 0 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 0 stocks
Track This Portfolio

Track Persistent Asset Partners LTD Portfolio

Follow Persistent Asset Partners LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Persistent Asset Partners LTD, based on Form 13F filings with the SEC.

News

Stay updated on Persistent Asset Partners LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email